Zura Bio Ltd (ZURA): who owns it and who trades it
As of Nov 16, 2026, ZURA insiders reported 1 purchase worth $12.5M in the last 12 months. The largest buyer was Access Industries Holdings LLC (10% owner), with $12.5M. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Zura Bio
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns ZURA
95 funds and institutions reported ZURA shares worth $430M at the end of Q2 2026, about 77% of the company. The largest holder is Montanova Capital, LLC with 10.0%.
Funds and institutions (13F) 77%Everyone else 23%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Montanova Capital, LLC | 9.44M | 9.95% | $55.7M | +4% |
| Venrock Adviser, LLC | 6.43M | 6.78% | $38M | No change |
| Mpm Bioimpact LLC | 4.47M | 4.71% | $26.4M | New |
| JPMorgan Chase & Co | 4.35M | 4.59% | $24.5M | New |
| Great Point Partners LLC | 4.22M | 4.44% | $24.9M | No change |
| Braidwell LP | 3.98M | 4.20% | $23.5M | -0% |
| Siren, L.L.C. | 3.73M | 3.94% | $22M | No change |
| BlackRock, Inc. | 3.61M | 3.81% | $21.3M | +690% |
| Commodore Capital LP | 3.25M | 3.43% | $19.2M | No change |
| Adage Capital Partners Gp, L.l.c. | 2.75M | 2.90% | $16.2M | No change |
| Saturn V Capital Management LP | 2.10M | 2.21% | $12.4M | +184% |
| QVT Financial LP | 1.90M | 2.00% | $11.2M | +45% |
| ADAR1 Capital Management, LLC | 1.76M | 1.85% | $10.4M | +179% |
| Armistice Capital, LLC | 1.64M | 1.72% | $9.7M | +9% |
| Geode Capital Management, LLC | 1.58M | 1.67% | $9.3M | +200% |
| Affinity Asset Advisors, LLC | 1.46M | 1.54% | $8.6M | -43% |
| Stempoint Capital LP | 1.37M | 1.44% | $8.1M | -9% |
| Ikarian Capital, LLC | 1.22M | 1.28% | $7.2M | +2% |
| EcoR1 Capital, LLC | 1.18M | 1.24% | $7M | No change |
| Vestal Point Capital, LP | 1.17M | 1.24% | $6.9M | +130% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, ZURA insiders reported $12.5M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Access Industries Holdings LLC +3 | 10% owner | Purchase | 2.00M | $6.25 | $12.5M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Access Industries Holdings LLC | 10% owner | $12.5M | – | Feb 26, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ZURA short interest
Moderate short interest. 8.8% of ZURA shares are sold short: about 1 share in 11. Over the last 12 reports the number of shares short went up 36%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 8.47M ZURA shares were sold short, 8.8% of the shares outstanding, up 20.7% from the report before. At the average daily volume of 4.73M shares, buying them all back would take about 1.8 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 8.47M | 8.79% | +21% | 4.73M | 1.8 |
| Oct 15, 2026 | 7.02M | 7.32% | -25% | 4.78M | 1.5 |
| Sep 30, 2026 | 9.37M | 9.77% | +0% | 1.96M | 4.8 |
| Sep 15, 2026 | 9.34M | 9.75% | -16% | 1.46M | 6.4 |
| Aug 31, 2026 | 11.10M | 11.58% | -3% | 1.91M | 5.8 |
| Aug 14, 2026 | 11.44M | 11.94% | +9% | 889,785 | 12.9 |
| Jul 31, 2026 | 10.51M | 11.08% | +3% | 536,902 | 19.6 |
| Jul 15, 2026 | 10.25M | 10.81% | +11% | 1.08M | 9.5 |
| Jun 30, 2026 | 9.24M | 9.74% | +57% | 2.28M | 4.0 |
| Jun 15, 2026 | 5.87M | 6.19% | -6% | 1.09M | 5.4 |
| May 29, 2026 | 6.22M | 6.56% | -0% | 685,361 | 9.1 |
| May 15, 2026 | 6.24M | 6.58% | -11% | 675,729 | 9.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Zura Bio company events
Zura Bio filed 19 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership). The latest was on Nov 9, 2026.
- Nov 9, 2026AnnouncementZura Bio Limited, a Cayman Islands exempted company, issued a press release providing a clinical update on the Company’s Phase 2 TibuSHIELD study of tibulizumab (ZB-106) in adults with moderate-to-severe hidradenitis suppurativa. Filing
- Oct 27, 2026ResultsReleased financial results. Filing
- Aug 17, 2026AnnouncementShared information with investors. Filing
- Aug 11, 2026ResultsReleased financial results. Filing
- Jul 1, 2026AnnouncementShared information with investors. Filing
- Jun 18, 2026LeadershipZura Bio Limited held its Annual General Meeting of Shareholders, at which a quorum was present. Filing
- May 22, 2026LeadershipSomeit Sidhu notified Zura Bio Limited of his decision to resign from the board of directors of the Company effective as of May 21, 2026. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Apr 23, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
- Mar 19, 2026ResultsReleased financial results. Filing
- Mar 10, 2026AnnouncementShared information with investors. Filing
- Mar 5, 2026AnnouncementShared information with investors. Filing
- Feb 26, 2026AgreementZura Bio Limited (the “ Company ’) entered into an underwriting agreement with Leerink Partners LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co., as representatives of the several underwriters listed therein, pursuant to which the Company agreed to issue and sell 18,200,000 Class A ordinary… Filing
- Feb 23, 2026LeadershipNeil Graham notified Zura Bio Limited of his decision to resign from the Company’s board of directors, effective February 21, 2026. Filing
- Feb 11, 2026AnnouncementShared information with investors. Filing
- Jan 26, 2026LeadershipRobert Lisicki notified the Board of Directors of Zura Bio Limited that he was resigning as the Company’s Chief Executive Officer, principal executive officer and member of the Board, effective as of January 21, 2026. Filing
- Jan 12, 2026AnnouncementThe Company issued a press release announcing certain corporate and clinical trial updates and its outlook for 2026, including updates on the Company’s cash runway and expected topline data readout timelines for its two ongoing Phase 2 clinical studies of tibulizumab, the Company’s lead… Filing
- Jan 2, 2026AgreementZura Bio Limited and its subsidiaries, Athanor Capital, an exempted company incorporated under the laws of the Cayman Islands with limited liability, Stone Peach Properties LLC, a Georgia limited liability company and its principals, and BAFFX17, a limited company incorporated under the laws of… Filing
- Dec 17, 2025LeadershipArnout Ploos van Amstel notified Zura Bio Limited of his decision to resign from the Board of Directors of the Company and as a member of the Nominating and Governance Committee of the Board effective immediately. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Zura Bio financials
Famous investors that hold ZURA
3 of the 50 well-known investors we track reported holding ZURA in their latest 13F filing. The largest position is Ken Griffin's, worth $3.9M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 939,784 | $3.9M | 0.0% | +213% |
| Israel Englander · Millennium Management | Q3 2026 | 745,761 | $3.1M | 0.0% | +442% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 50,700 | $211K | 0.0% | -84% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Zura Bio Ltd (ZURA) stock
Who owns the most ZURA stock?
The largest reported owner of Zura Bio Ltd (ZURA) is Montanova Capital, LLC, with 10.0% of the company. In total, 95 funds and institutions reported holding ZURA at the end of Q2 2026, together about 77% of the shares. See the largest owners.
Are ZURA insiders buying or selling?
In the last 12 months, ZURA insiders reported 1 open-market purchase worth $12.5M and no sales. The latest trade was on Feb 26, 2026. See every trade.
What is the short interest in ZURA?
As of Oct 30, 2026, 8.47M ZURA shares were sold short, 8.8% of the shares outstanding, up 20.7% from the report before. At the average daily volume of 4.73M shares, buying them all back would take about 1.8 trading days (days to cover). See the history.
Which famous investors hold ZURA?
3 of the 50 well-known investors we track reported ZURA in their latest 13F filing, including Ken Griffin, Israel Englander, Jim Simons. The largest position is worth $3.9M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.